The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A therapeutic vaccine for fibrolamellar hepatocellular carcinoma.
 
Marina Baretti
Consulting or Advisory Role - AstraZeneca; Incyte
Research Funding - Merck (Inst)
 
Allison Kirk
No Relationships to Disclose
 
Brian Ladle
No Relationships to Disclose
 
Kayla Bendinelli
No Relationships to Disclose
 
Zeal Kamdar
No Relationships to Disclose
 
Won Ho
No Relationships to Disclose
 
Samir Adhikari
No Relationships to Disclose
 
Balaji Sundararaman
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Jeric Hernandez
No Relationships to Disclose
 
Hanfei Qi
No Relationships to Disclose
 
Mari Nakazawa
No Relationships to Disclose
 
Mark Furth
No Relationships to Disclose
 
Robert Anders
No Relationships to Disclose
 
Christopher Thoburn
No Relationships to Disclose
 
Julie Nauroth
No Relationships to Disclose
 
Elizabeth Jaffee
Stock and Other Ownership Interests - ABMETA Therapeutics; Adventris
Consulting or Advisory Role - Achilles Therapeutics; Dragonfly Therapeutics; Medically Home; Mestag Therapeutics; NeoTX; NEUVOGEN; SURGE Therapeutics
Research Funding - Breast Cancer Research Foundation; Bristol-Myers Squibb; Lucence Diagnostics; Roche
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
Other Relationship - Break Through Cancer; CPRIT; Parker Institute; Parker Institute
 
Mikhail Pogorelyy
No Relationships to Disclose
 
Paul Thomas
No Relationships to Disclose
 
Mark Yarchoan
Leadership - Adventris Pharmaceuticals
Stock and Other Ownership Interests - Adventris Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Exelixis; Genentech/Roche; Incyte; Lantheus Medical Imaging
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to therapeutic cancer vaccines, managed by Johns Hopkins
(OPTIONAL) Uncompensated Relationships - Merck